Asha Kandathil MD, Presenter: Nothing to Disclose

Peter Shou-Cheng Liu MD, Abstract Co-Author: Nothing to Disclose

William J. Weadock MD, Abstract Co-Author: Owner, Weadock Software, LLC

Hero Kamal Hussain MD, Abstract Co-Author: Consultant, Bayer AG

1. BCLC staging system for hepatocellular carcinoma 2. Role of magnetic resonance imaging (MRI) in diagnosis and staging of HC 3. Treatment options available for various BCLC stages of HCC with focus on loco-regional therapeutic options such as percutaneous ablation, transarterial chemoembolization (TACE), radioembolization, stereotactic radiotherapy 4. Role of MRI in assessing therapeutic response in HCC

1. Overview of BCLC staging system for hepatocellular carcinoma 2. Case based presentation of various BCLC stages of HCC illustrating - MRI evaluation of tumor extent - appropriate loco-regional therapies - follow up MRI assessing post therapeutic response

http://abstract.rsna.org/uploads/2014/14002818/14002818_mxuw.pdf

Kandathil, A, Liu, P, Weadock, W, Hussain, H, Role of Imaging in Staging, Management and Follow-up of Patients with Hepatocellular Carcinoma (HCC) based on the Barcelona Clinic for Liver Cancer (BCLC) Staging System.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14002818.html